High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand-Reference-Cited by-同舟云学术

High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand

Published:2022-12 Issue: Volume:125 Page:177-183
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Pasittungkul Siripat,Thongpan Ilada,Vichaiwattana Preeyaporn,Thongmee Thanunrat,Klinfueng Sirapa,Suntronwong Nungruthai^ORCID,Wanlapakorn Nasamon^ORCID,Vongpunsawad Sompong,Poovorawan Yong

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference24 articles.

1. Vertically transferred immunity in neonates: mothers, mechanisms and mediators;Albrecht;Front Immunol,2020

2. Protective and disease-enhancing immune responses to respiratory syncytial virus;Anderson;J Infect Dis,1995

3. Seroepidemiology of respiratory syncytial virus in western India with special reference to appropriate age for infant vaccination;Arankalle;J Med Virol,2019

4. Seroprevalence of anti-RSV IgG in Thai children aged 6 months to 5 years;Bhattarakosol;Asian Pac J Allergy Immunol,2003

5. Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection;Brandenburg;J Med Virol,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Independent Analysis of the Results of the First Infant Immunization Campaign with Beyfortus® (Nirsevimab, Monoclonal Antibody Against RSV Bronchiolitis Virus): Mixed Results, Identification of Biases, and Possible Role and Mechanisms of ADE (Antibody Dependent Enhancement);2024-06-11

2. Epidemiology and molecular analyses of respiratory syncytial virus in the 2021–2022 season in northern Italy;Frontiers in Microbiology;2024-01-04

3. Adjusted Seroepidemiology Pattern from ELISA Test for Respiratory Syncytial Virus;Clinical Laboratory;2023